Lexicon Pharmaceuticals
LXRX
#6713
Rank
ยฃ0.59 B
Marketcap
ยฃ1.33
Share price
-1.68%
Change (1 day)
20.37%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -ยฃ0.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.11. In 2025 the company made an earnings per share (EPS) of -ยฃ0.11 an increase over its 2024 EPS that were of -ยฃ0.49.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.11-0.96%
2025-ยฃ0.11-78.13%
2024-ยฃ0.49-20%
2023-ยฃ0.6131.15%
2022-ยฃ0.46-0%
2021-ยฃ0.4610.91%
2020-ยฃ0.42-145.08%
2019ยฃ0.93-206.09%
2018-ยฃ0.87-5.74%
2017-ยฃ0.93-10.95%
2016-ยฃ1.042640%
2015-ยฃ0.03792-96.34%
2014-ยฃ1.03-2.53%
2013-ยฃ1.06-9.09%
2012-ยฃ1.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ14.40-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.47-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ35.62-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ3.94 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.96-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01517-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.57 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06825-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ22.21 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA